Aggregation of human recombinant alpha-synuclein
Minee L Choi
Abstract
This protocol describes a method of generating aggregation of human recombinant alpha-synuclein.
Steps
Humanrecombinant α-Syn Monomeric WTα-Syn is purified from Escherichia coli as
previously described in
Aggregation reactions are carried out using a solution of α-Syn 70micromolar (µM)
in 25millimolar (mM)
Tris buffervsupplemented with 100millimolar (mM)
NaCl, 7.4
(in the presence of 0.01% volume
% NaN3 to prevent bacterial growth).
The buffer is freshly prepared before each experiment and passed through a 0.02 µm
syringe filter (Anotop, Whatman) to remove insoluble contaminants.
Prior to incubation, the reaction mixture is ultra-centrifuged at 90k r.p.m. for 1h 0m 0s
at
4°C
to remove potential seeds.
The supernatant is collected and separated in two fractions: one kept at 4°C
at all
times until use(monomers), and a second incubated in the dark at 37°C37°C
and200rpm,0h 0m 0s
, during7h 0m 0s
-8h 0m 0s
hours to avoid fibril formation (monomers+oligomers).
α-Syn is always kept in LoBind microcentrifuge tubes (Eppendorf, Hamburg, Germany) to
limit surface adsorption.